Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:CAPDNASDAQ:PRE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCAPDiPath Shiller CAPE ETN$19.37+0.2%$19.37$17.73▼$23.10$335.88MN/A120,878 shs263,800 shsPREPrenetics Global$8.04+1.6%$7.48$3.09▼$11.99$98.03M0.1522,453 shs30,767 shs10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCAPDiPath Shiller CAPE ETN0.00%0.00%0.00%0.00%0.00%PREPrenetics Global-4.47%+1.54%-14.02%+102.56%+36.14%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCAPDiPath Shiller CAPE ETNN/AN/AN/AN/AN/AN/AN/AN/APREPrenetics Global1.9349 of 5 stars2.54.00.00.02.00.01.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCAPDiPath Shiller CAPE ETN 0.00N/AN/AN/APREPrenetics Global 3.00Buy$9.0012.01% UpsideCurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCAPDiPath Shiller CAPE ETNN/AN/AN/AN/AN/AN/APREPrenetics Global$30.62M3.20N/AN/A$14.04 per share0.57Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCAPDiPath Shiller CAPE ETNN/AN/A0.00∞N/AN/AN/AN/AN/APREPrenetics Global-$46.30M-$3.99N/AN/AN/A-115.91%-28.07%-22.27%N/ALatest GWMO, SOLG, PRE, and CAPD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/12/2025Q1 2025PREPrenetics GlobalN/A-$0.80N/A-$0.80N/A$17.31 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCAPDiPath Shiller CAPE ETNN/A0.00%N/AN/AN/APREPrenetics GlobalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCAPDiPath Shiller CAPE ETNN/AN/AN/APREPrenetics GlobalN/A2.071.89Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCAPDiPath Shiller CAPE ETNN/APREPrenetics Global25.01%Insider OwnershipCompanyInsider OwnershipCAPDiPath Shiller CAPE ETNN/APREPrenetics Global7.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCAPDiPath Shiller CAPE ETNN/A17.34 millionN/ANot OptionablePREPrenetics Global112.20 million11.25 millionNot OptionableGWMO, SOLG, PRE, and CAPD HeadlinesRecent News About These CompaniesPrenetics Global Limited (PRE) - Yahoo FinanceJune 30 at 5:50 PM | finance.yahoo.comAryna Sabalenka Adds Her Muscle to IM8 as Ambassador & ShareholderJune 30 at 5:50 PM | msn.comAryna Sabalenka Becomes First Current Athlete Shareholder in Prenetics' IM8 Supplements BrandJune 26, 2025 | quiverquant.comQWorld No. 1 Tennis Star Aryna Sabalenka Joins Prenetics' IM8 Health as Global Ambassador and ShareholderJune 26, 2025 | globenewswire.comCardone Capital goes all-in on Bitcoin adding 1K BTC to its reserveJune 23, 2025 | msn.com$1.24 Billion in Bitcoin Added to Corporate Treasuries This WeekJune 22, 2025 | coingape.comCA South Korean Biotech Firms Gets $183.3M Funding to Build Bitcoin TreasuryJune 21, 2025 | coindesk.comHealthcare Meets Crypto: David Beckham–Backed Prenetics Launches $20M Bitcoin TreasuryJune 20, 2025 | techstory.inTPrenetics Global (NASDAQ:PRE) Stock, Short Interest ReportJune 19, 2025 | benzinga.comPrenetics Adopts $20M Bitcoin Treasury StrategyJune 19, 2025 | thecurrencyanalytics.comTPrenetics Global First Quarter 2025 Earnings: Revenues Beat Expectations, EPS In LineJune 19, 2025 | finance.yahoo.comPrenetics Becomes First Healthcare Company to Execute Aggressive Bitcoin Treasury Strategy, Secures $20M in BTC, Appoints Former OKEx COO to BoardJune 18, 2025 | globenewswire.comPrenetics Global Limited Divests ACT Genomics, Strengthens Financial Position and Raises FY2025 Revenue OutlookJune 18, 2025 | quiverquant.comQPrenetics Divests ACT Genomics to Delta Electronics as Part of up to US$71.78 Million TransactionJune 18, 2025 | globenewswire.comShort Interest in Prenetics Global Limited (NASDAQ:PRE) Increases By 46.2%June 16, 2025 | marketbeat.comPrenetics Global Limited Appoints New Independent Director to Strengthen Bitcoin StrategyJune 16, 2025 | tipranks.comBrokers Set Expectations for PRE FY2026 EarningsJune 16, 2025 | marketbeat.comPrenetics Global reports Q1 2025 financialsJune 14, 2025 | uk.investing.comPrenetics Announces First Quarter 2025 Financial Results, Raises FY2025 Outlook, & Crypto Strategy Announcement SoonJune 14, 2025 | nasdaq.comPrenetics Global (NASDAQ:PRE) Issues Quarterly Earnings ResultsJune 12, 2025 | marketbeat.comPrenetics Global Full Year 2024 Earnings: Misses ExpectationsMay 3, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesChime’s Smart IPO: Half the Valuation, Double the StrengthBy Jeffrey Neal Johnson | June 18, 2025View Chime’s Smart IPO: Half the Valuation, Double the StrengthLululemon, UNH, Enphase: Bad News, Good Opportunity?By Thomas Hughes | June 17, 2025View Lululemon, UNH, Enphase: Bad News, Good Opportunity?Which Analyst-Favorite Drone Stock Will Come Out on Top?By Nathan Reiff | June 25, 2025View Which Analyst-Favorite Drone Stock Will Come Out on Top?RKLB Breakout Fails Near Highs: Should Investors Be Concerned?By Ryan Hasson | June 11, 2025View RKLB Breakout Fails Near Highs: Should Investors Be Concerned?Costco at a Crossroads: Is the Next Move Higher or Lower?By Dan Schmidt | June 25, 2025View Costco at a Crossroads: Is the Next Move Higher or Lower?GWMO, SOLG, PRE, and CAPD Company DescriptionsiPath Shiller CAPE ETN NYSEARCA:CAPD$19.37 +0.04 (+0.21%) As of 10/11/2022Prenetics Global NASDAQ:PRE$8.04 +0.13 (+1.58%) As of 01:25 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Why Occidental's Price Dip Signals a Buying Opportunity Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Rocket Lab: Latest Catalysts Bolster the Bull Case Nike's Stock Just Got an Upgrade: Is a Real Comeback Brewing? Why Hims & Hers Is a Buy Below $35 After Its 16% Pullback Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
